Lilly to sell obesity drugs directly on Hims & Hers site
Summary
Eli Lilly said on Friday it struck a deal to allow Hims & Hers Health to sell obesity drugs Zepbound and Foundayo directly on its platform, sending the telehealth... Covered by 3 outlets: 1 lean left, 2 are centre.
Automated summary picked from the outlets' own descriptions.
Who is covering this
-
Lilly to sell obesity drugs directly on Hims & Hers site - Reuters
Lilly to sell obesity drugs directly on Hims & Hers site Reuters
-
Eli Lilly is partnering with Hims & Hers to sell its weight loss drugs
The agreement covers Zepbound and Foundayo for patients who pay out of pocket through the telehealth platform
-
Lilly to Sell Obesity Drugs Directly on Hims & Hers Site
Eli Lilly said on Friday it struck a deal to allow Hims & Hers Health to sell obesity drugs Zepbound and Foundayo directly on its platform, sending the telehealth... Reuters Health Information
Related stories
Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump
2 sourcesvia ReutersTruth score 551
We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
1 sourcevia Google NewsTruth score 41
Doctors in England launch primary-care trial of blood tests for spotting cancer early
2 sourcesvia ReutersTruth score 52
US hospitals brace for tougher 2027 as coverage losses and Medicaid cuts loom
2 sourcesvia Times of IndiaTruth score 48
Albertsons Must Pay $900 Million for Fueling Opioid Epidemic in Washington State, Judge Rules
1 sourcevia MedscapeTruth score 38
Yemen war: Pregnant women struggle to access life-saving healthcare
3 sourcesvia Al Jazeera EnglishTruth score 571
Comments
Comments need JavaScript.